In the News

Heru registers AI vision test with FDA, begins commercialization pilot

December 28, 2020 – BioWorld

Medical technology company Heru, Inc completes FDA registration following a $2.7M seed round

December 22, 2020 – Ophthalmology360

Cloud-based augmented/virtual reality platform receives class I listing with FDA

December 21, 2020 – Ophthalmology Times

Be the first to know

Receive product updates and get early access to Heru technologies.